Form 4: PKBK Director Exercises Options, Sells Shares, Gets RSUs

Sentiment:

Insider Transaction Report


A director at Parke Bancorp, Inc. exercised stock options, sold shares, and received restricted stock units, adjusting their beneficial ownership.

Summary

  • Elizabeth A. Milavsky, a Director at Parke Bancorp, Inc. (PKBK), reported several equity transactions.
  • On December 24, 2025, Milavsky exercised stock options to acquire 10,981 shares of common stock at an exercise price of $7.81 per share.
  • Concurrently, on December 24, 2025, Milavsky sold 10,981 shares of common stock at a price of $24.71 per share.
  • On October 21, 2025, Milavsky was granted 2,500 restricted stock units (RSUs), which are scheduled to vest 20% per year over 5 years, converting into one share of common stock upon vesting.
  • Following these transactions, Milavsky directly owns 35,278 shares of common stock and indirectly owns 16,544 shares through a 401K.
  • Milavsky also holds remaining stock options for 1,650 shares at $20.14, 22,500 shares at $12.29, and 5,000 shares at $21.66.

Sentiment

Score: 7

Explanation: The director realized a significant profit from option exercise and sale, and received new long-term equity compensation (RSUs), indicating continued alignment with the company's future. While there was a sale, it was offset by the RSU grant and remaining options, suggesting a generally positive outlook for the insider.

Positives

  • The director realized a significant profit from the option exercise and subsequent sale, with shares sold at $24.71 compared to an exercise price of $7.81.
  • The grant of 2,500 restricted stock units aligns the director's long-term interests with shareholder value through future vesting.

Negatives

  • The sale of 10,981 shares by a director, even as part of an option exercise, represents a reduction in direct insider ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: The director's profitable exercise of options and subsequent sale could be viewed as a positive sign of the stock's value, while the RSU grant reinforces long-term alignment. The net effect on direct ownership is a slight decrease, but overall equity exposure remains substantial.

Next Steps

  • Vesting of 2,500 restricted stock units, 20% annually over 5 years, commencing October 21, 2026.

Key Dates

DateDescription
01/19/2017Date stock options with an exercise price of $7.81 became exercisable.
08/22/2019Date stock options with an exercise price of $20.14 became exercisable.
04/24/2021Date stock options with an exercise price of $12.29 became exercisable.
06/13/2023Date stock options with an exercise price of $21.66 became exercisable.
10/21/2025Date of grant for 2,500 restricted stock units.
12/24/2025Date of option exercise and subsequent sale of common stock.
12/26/2025Signature date of the Form 4 filing.
01/19/2026Expiration date for stock options with an exercise price of $7.81.
10/21/2026Date the first tranche of restricted stock units begins to vest (20% per year for 5 years).
08/22/2028Expiration date for stock options with an exercise price of $20.14.
04/24/2030Expiration date for stock options with an exercise price of $12.29.
06/12/2032Expiration date for stock options with an exercise price of $21.66.
10/21/2035Expiration date for restricted stock units.

Recommendation

hold

The filing details routine insider transactions involving option exercise, share sale, and RSU grant. While the director realized a profit and reduced direct share count, the new RSU grant maintains long-term alignment. These transactions are generally expected for insiders managing their equity compensation and do not signal a strong 'buy' or 'sell' based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Parke Bancorp, PKBK, Form 4, insider trading, stock options, restricted stock units, director transactions, equity compensation, beneficial ownership, stock sale, option exercise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.